As part of our ongoing seminar series, the Centre of Research Excellence in Severe Asthma is pleased to be hosting Dr Mario Castro (Washington University School of Medicine, St Louis, MO) on 19 June 2018.
To download the event flyer: click here
1 – 2PM AEDT: Dr Mario Castro (Washington University School of Medicine, St Louis, MO) will present “Severe Asthma Data from SARP”
The recorded webinar is now available on this site: Click here
If you are interested in hearing more about our events and research, please subscribe to our email list on our homepage, or follow us on Twitter (@SevereAsthmaCRE).
Before watching this webinar, you may be interested in learning more about Severe Asthma, from the Severe Asthma Toolkit.
Bio: Dr Mario Castro, MPH, FCCP is Alan A. and Edith L. Wolff Professor of Pulmonary and Critical Care Medicine.
Dr Castro is Professor of Medicine and Pediatrics, Division of Pulmonary and Critical Care Medicine at the Washington University School of Medicine in St. Louis, MO.
Dr Castro’s specialties include asthma and related allergic disease, COPD, emphysema, chronic bronchitis, chronic cough and unexplained shortness of breath. Dr Castro is active in research and is working under several grants from the National Institutes of Health (NIH) regarding the causes of asthma, especially severe asthma, as part of the Severe Asthma Research Program (SARP).
He is the Principal Investigator of several networks sponsored by the NIH, Patient-Centered Outcomes Research Institute and American Lung Association, evaluating the management and treatment of asthma and airway diseases. He has been a Member of the Scientific Advisory Board at Therabron Therapeutics, Inc. since May 19 2016. He is the recipient of numerous awards and is author or co-author of more than 200 peer reviewed articles.
Dr Castro is Board Certified in Pulmonary Disease, Internal Medicine and Critical Care Medicine. Dr Castro received his medical degree from the University of Missouri – Kansas City School of Medicine. He completed his fellowship in Pulmonary/Critical Care and his Residency in Internal Medicine, at the Mayo Clinic and earned a graduate degree in Public Health from St. Louis University School of Public Health.
Dr. Castro’s travel and the refreshments for this event have been supported by funding from AstraZeneca.
